The big and small of drug discovery - Biotech versus pharma: advantages and drawbacks in drug development

被引：44

|

作者：

Moore, A

机构：

来源：

EMBO REPORTS | 2003年 / 4卷 / 02期

关键词：

D O I：

10.1038/sj.embor.embor748

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：114 / 117

页数：4

相关论文

共 50 条

[1] Drug discovery successes in nonprofits and biotech/pharma collaborations
Conn, P. Jeffrey
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[2] A better fit? Biotech versus Big Pharma in orphan/rare disease drug research
O'Neil, Deborah A.
EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 317 - 319
[3] Antibacterial drug discovery: is small pharma the solution?
Boggs, AF
Miller, GH
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 : 32 - 36
[4] Partnership between small biotech and big pharma
Wiederrecht, Gregory J.
Hill, Raymond G.
Beer, Margaret S.
IDRUGS, 2006, 9 (08) : 560 - 564
[5] Small molecule discovery at big pharma and small biotech: Factor Xa inhibitors and RORγ agonists
VanHuis, Chad
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[6] Why is big Pharma getting out of antibacterial drug discovery?
Projan, SJ
CURRENT OPINION IN MICROBIOLOGY, 2003, 6 (05) : 427 - 430
[7] Biotech pharma raises US$112 million for CNS drug development
不详
PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2023, 27 (02) : 42 - 42
[8] Drug delivery and big pharma
Wyatt, D. A.
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A75 - A75
[9] Medicinal chemistry in drug discovery in big pharma: past, present and future
Campbell, Ian B.
Macdonald, Simon J. F.
Procopiou, Panayiotis A.
DRUG DISCOVERY TODAY, 2018, 23 (02) : 219 - 234
[10] DRUG FIRMS NEED BIOTECH DRUG DISCOVERY
STONE, D
BIO-TECHNOLOGY, 1995, 13 (03): : 208 - 209

← 1 2 3 4 5 →